Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19

Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19

Background: Hydroxychloroquine (HC) ± azithromycin (AZ) is widely used for Covid-19. The Qatar Prospective RCT of Expediting Coronavirus Tapering (Q-PROTECT) aimed to assess virologic cure rates of HC±AZ in cases of low-acuity Covid-19. Methods: Q-PROTECT employed a prospective, placebo-controlled d...

Full description

Bibliographic Details
Main Authors: Ali S. Omrani, Sameer A. Pathan, Sarah A. Thomas, Tim R.E. Harris, Peter V. Coyle, Caroline E. Thomas, Isma Qureshi, Zain A. Bhutta, Naema Al Mawlawi, Reham Al Kahlout, Ashraf Elmalik, Aftab M. Azad, Joanne Daghfal, Mulham Mustafa, Andrew Jeremijenko, Hussam Al Soub, Mohammed Abu Khattab, Muna Al Maslamani, Stephen H. Thomas
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:EClinicalMedicine
Subjects:
Hyodroxychloroquine
Covid-19
Azithromycin
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537020303898

Internet

http://www.sciencedirect.com/science/article/pii/S2589537020303898

Similar Items